Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
10.1038/s41368-023-00252-1
- Author:
Kelsey A CARPENTER
1
;
Delia O ALKHATIB
1
;
Bryan A DULION
1
;
Elizabeth GUIRADO
2
;
Shreya PATEL
1
;
Yinghua CHEN
2
;
Anne GEORGE
2
;
Ryan D ROSS
3
Author Information
1. Department of Anatomy & Cell Biology, Rush University Medical Center, Chicago, IL, USA.
2. Department of Oral Biology, The University of Illinois at Chicago, Chicago, IL, USA.
3. Department of Anatomy & Cell Biology, Rush University Medical Center, Chicago, IL, USA. Ryan_ross@rush.edu.
- Publication Type:Research Support, N.I.H., Extramural
- MeSH:
Mice;
Male;
Female;
Animals;
Familial Hypophosphatemic Rickets/metabolism*;
Bone and Bones/metabolism*;
Tooth/metabolism*;
Periodontal Ligament/metabolism*
- From:
International Journal of Oral Science
2023;15(1):47-47
- CountryChina
- Language:English
-
Abstract:
X-linked hypophosphatemia (XLH) is a rare disease of elevated fibroblast growth factor 23 (FGF23) production that leads to hypophosphatemia and impaired mineralization of bone and teeth. The clinical manifestations of XLH include a high prevalence of dental abscesses and periodontal disease, likely driven by poorly formed structures of the dentoalveolar complex, including the alveolar bone, cementum, dentin, and periodontal ligament. Our previous studies have demonstrated that sclerostin antibody (Scl-Ab) treatment improves phosphate homeostasis, and increases long bone mass, strength, and mineralization in the Hyp mouse model of XLH. In the current study, we investigated whether Scl-Ab impacts the dentoalveolar structures of Hyp mice. Male and female wild-type and Hyp littermates were injected with 25 mg·kg-1 of vehicle or Scl-Ab twice weekly beginning at 12 weeks of age and euthanized at 20 weeks of age. Scl-Ab increased alveolar bone mass in both male and female mice and alveolar tissue mineral density in the male mice. The positive effects of Scl-Ab were consistent with an increase in the fraction of active (nonphosphorylated) β-catenin, dentin matrix protein 1 (DMP1) and osteopontin stained alveolar osteocytes. Scl-Ab had no effect on the mass and mineralization of dentin, enamel, acellular or cellular cementum. There was a nonsignificant trend toward increased periodontal ligament (PDL) attachment fraction within the Hyp mice. Additional PDL fiber structural parameters were not affected by Scl-Ab. The current study demonstrates that Scl-Ab can improve alveolar bone in adult Hyp mice.
